Authors: Renau, TE Leger, R Flamme, EM She, MW Gannon, CL Mathias, KM Lomovskaya, O Chamberland, S Lee, VJ Ohta, T Nakayama, K Ishida, Y

Citation: Te. Renau et al., Addressing the stability of C-capped dipeptide efflux pump inhibitors thatpotentiate the activity of levofloxacin in Pseudomonas aeruginosa, BIOORG MED, 11(5), 2001, pp. 663-667

Authors: Renau, TE

Citation: Te. Renau, Antibacterial drug development - Preface, CURR MED CH, 8(14), 2001, pp. NIL_2-NIL_2

Authors: Watkins, WJ Renau, TE

Citation: Wj. Watkins et Te. Renau, Progress with antifungal agents and approaches to combat fungal resistance, ANNU REP M, 35, 2000, pp. 157-166

Authors: Jacobson, JG Renau, TE Nassiri, MR Sweier, DG Breitenbach, JM Townsend, LB Drach, JC

Citation: Jg. Jacobson et al., Nonnucleoside pyrrolopyrimidines with a unique mechanism of action againsthuman cytomegalovirus, ANTIM AG CH, 43(8), 1999, pp. 1888-1894

Authors: Renau, TE Leger, R Flamme, EM Sangalang, J She, MW Yen, R Gannon, CL Griffith, D Chamberland, S Lomovskaya, O Hecker, SJ Lee, VJ Ohta, T Nakayama, K

Citation: Te. Renau et al., Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin, J MED CHEM, 42(24), 1999, pp. 4928-4931